A Multi Center, Prospective, Observational, Open-label, Pharmacokinetic Study of Tacrolimus in Heart and Lung Transplantation Patients during the First Days after Transplantation.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 22 Oct 2015
At a glance
- Drugs Tacrolimus (Primary)
- Indications Heart-lung transplant rejection
- Focus Pharmacokinetics
- Acronyms SPARTACUS
- 15 Oct 2015 Status changed from planning to active, no longer recruiting, according to Netherlands Trial Register record.
- 15 Apr 2013 New trial record